NRICM101 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "NRICM101" in English language version.

refsWebsite

Global rank English rank

6nih.gov

4^th place

4doi.org

2^nd place

3web.archive.org

1^st place

2taiwannews.com.tw

3,205^th place

2,266^th place

2nricm.edu.tw

low place

1taipeitimes.com

1,398^th place

881^st place

1mofa.gov.tw

5,366^th place

low place

1americanscientist.org

7,231^st place

5,635^th place

1mohw.gov.tw

low place

1pts.org.tw

4,825^th place

low place

1researchgate.net

120^th place

125^th place

1diarioelnorte.com.ar

low place

americanscientist.org

Hungyin Tsai (September–October 2022). "The History of Vaccine Uptake in Taiwan". American Scientist. Vol. 110, no. 5. p. 292. doi:10.1511/2022.110.5.292.

diarioelnorte.com.ar

"Un medicamento, una mie y un aceite fueron prohibidos por la ANMAT". Diario el Norte. 2021-10-22. Archived from the original on 2024-02-06. Retrieved 2022-05-18.

doi.org

Hungyin Tsai (September–October 2022). "The History of Vaccine Uptake in Taiwan". American Scientist. Vol. 110, no. 5. p. 292. doi:10.1511/2022.110.5.292.
Ho ST, Tsai YN, Su YC (July 2023). "The development and application of NRICM101 and NRICM102 for the treatment of COVID-19". Journal of the Formosan Medical Association. 122 (7): 525–527. doi:10.1016/j.jfma.2023.04.015. PMC 10130323. PMID 37147240.
Keng-Chang Tsai; Yi-Chia Huang; Chia-Ching Liaw; Chia-I Tsai; Chun-Tang Chiou; Chien-Jung Lin; Wen-Chi Wei; Sunny Jui-Shan Lin; Yu-Hwei Tseng; Kuo-Ming Yeh; Yi-Ling Lin; Jia-Tsrong Jan; Jian-Jong Liang; Chun-Che Liao; Wen-Fei Chiou; Yao-Haur Kuo; Shen-Ming Lee; Ming-Yung Lee; Yi-Chang Su (January 2021). "A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study". Biomedicine & Pharmacotherapy. 133 (111037): 111037. doi:10.1016/j.biopha.2020.111037. PMC 7676327. PMID 33249281.
Ho, ST; Tsai, YN; Su, YC (July 2023). "The development and application of NRICM101 and NRICM102 for the treatment of COVID-19". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 122 (7): 525–527. doi:10.1016/j.jfma.2023.04.015. PMC 10130323. PMID 37147240.

mofa.gov.tw

nspp.mofa.gov.tw

"A TCM Prescription for Covid: Taiwan's NRICM101". New Southbound Policy Portal. Ministry of Foreign Affairs of the Republic of China (Taiwan). 25 April 2022.

mohw.gov.tw

service.mohw.gov.tw

衛生福利部 (2020-09-02). ""順天堂"RespireAid 臺灣清冠一號濃縮顆粒". 中藥許可證查詢 (in Chinese (Taiwan)). Archived from the original on 2021-02-05. Retrieved 2021-02-03. 效能:解表宣肺、清熱解毒、寬胸化痰、和胃降氣。適應症:外感時疫。

nih.gov

ncbi.nlm.nih.gov

Ho ST, Tsai YN, Su YC (July 2023). "The development and application of NRICM101 and NRICM102 for the treatment of COVID-19". Journal of the Formosan Medical Association. 122 (7): 525–527. doi:10.1016/j.jfma.2023.04.015. PMC 10130323. PMID 37147240.
Keng-Chang Tsai; Yi-Chia Huang; Chia-Ching Liaw; Chia-I Tsai; Chun-Tang Chiou; Chien-Jung Lin; Wen-Chi Wei; Sunny Jui-Shan Lin; Yu-Hwei Tseng; Kuo-Ming Yeh; Yi-Ling Lin; Jia-Tsrong Jan; Jian-Jong Liang; Chun-Che Liao; Wen-Fei Chiou; Yao-Haur Kuo; Shen-Ming Lee; Ming-Yung Lee; Yi-Chang Su (January 2021). "A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study". Biomedicine & Pharmacotherapy. 133 (111037): 111037. doi:10.1016/j.biopha.2020.111037. PMC 7676327. PMID 33249281.
Ho, ST; Tsai, YN; Su, YC (July 2023). "The development and application of NRICM101 and NRICM102 for the treatment of COVID-19". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 122 (7): 525–527. doi:10.1016/j.jfma.2023.04.015. PMC 10130323. PMID 37147240.

pubmed.ncbi.nlm.nih.gov

Ho ST, Tsai YN, Su YC (July 2023). "The development and application of NRICM101 and NRICM102 for the treatment of COVID-19". Journal of the Formosan Medical Association. 122 (7): 525–527. doi:10.1016/j.jfma.2023.04.015. PMC 10130323. PMID 37147240.
Keng-Chang Tsai; Yi-Chia Huang; Chia-Ching Liaw; Chia-I Tsai; Chun-Tang Chiou; Chien-Jung Lin; Wen-Chi Wei; Sunny Jui-Shan Lin; Yu-Hwei Tseng; Kuo-Ming Yeh; Yi-Ling Lin; Jia-Tsrong Jan; Jian-Jong Liang; Chun-Che Liao; Wen-Fei Chiou; Yao-Haur Kuo; Shen-Ming Lee; Ming-Yung Lee; Yi-Chang Su (January 2021). "A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study". Biomedicine & Pharmacotherapy. 133 (111037): 111037. doi:10.1016/j.biopha.2020.111037. PMC 7676327. PMID 33249281.
Ho, ST; Tsai, YN; Su, YC (July 2023). "The development and application of NRICM101 and NRICM102 for the treatment of COVID-19". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 122 (7): 525–527. doi:10.1016/j.jfma.2023.04.015. PMC 10130323. PMID 37147240.

nricm.edu.tw

國家中醫藥研究所官網. "臺灣清冠一號已取得多國藥證、草藥許可和膳食許可證等". 衛生福利部國家中醫藥研究所. Archived from the original on 2022-06-23. Retrieved 2022-06-13.
"[公告] : 「臺灣清冠二號」僅適用缺氧重症患者，未經中醫師診療，切勿自行購買藥材煎煮，以免傷身!". 衛生福利部國家中醫藥研究所 (in Chinese (Taiwan)). 2022-09-13.

pts.org.tw

news.pts.org.tw

G. Chen (4 October 2022). "RespireAid Tested Effective Against COVID-19 Variants 清冠一號最新研究抗新冠變異株更有效". 公視新聞網 PNN. Public Television Service.

researchgate.net

Keng-Chang Tsai; Yi-Chia Huang; Chia-Ching Liaw; Chia-I Tsai; Chun-Tang Chiou; Chien-Jung Lin; Wen-Chi Wei; Sunny Jui-Shan Lin; Yu-Hwei Tseng; Kuo-Ming Yeh; Yi-Ling Lin; Jia-Tsrong Jan; Jian-Jong Liang; Chun-Che Liao; Wen-Fei Chiou; Yao-Haur Kuo; Shen-Ming Lee; Ming-Yung Lee; Yi-Chang Su (January 2021). "A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study". Biomedicine & Pharmacotherapy. 133 (111037): 111037. doi:10.1016/j.biopha.2020.111037. PMC 7676327. PMID 33249281.

taipeitimes.com

"Herbal formula lauded as COVID-19 treatment". Taipei Times. CNA. 25 April 2022.

taiwannews.com.tw

Huang Tzu-ti (27 May 2021). "Pharmaceutical donates COVID herbal drug to hospitals in Taiwan". Taiwan News.
Huang Tzu-ti (15 March 2021). "Herbal COVID medicine from Taiwan takes West by storm". Taiwan News.

web.archive.org

衛生福利部 (2020-09-02). ""順天堂"RespireAid 臺灣清冠一號濃縮顆粒". 中藥許可證查詢 (in Chinese (Taiwan)). Archived from the original on 2021-02-05. Retrieved 2021-02-03. 效能:解表宣肺、清熱解毒、寬胸化痰、和胃降氣。適應症:外感時疫。
國家中醫藥研究所官網. "臺灣清冠一號已取得多國藥證、草藥許可和膳食許可證等". 衛生福利部國家中醫藥研究所. Archived from the original on 2022-06-23. Retrieved 2022-06-13.
"Un medicamento, una mie y un aceite fueron prohibidos por la ANMAT". Diario el Norte. 2021-10-22. Archived from the original on 2024-02-06. Retrieved 2022-05-18.